Device Radiology

Safeguard Focus

Payments companies reported to CMS as associated with Safeguard Focus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$350Kassociated payments (2023-2025)
12clinicians with associated payments
1company reporting

By year

2023 $65K
2024 $126K
2025 $159K

Payments reported as associated with Safeguard Focus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $346K
General Practice $3,563
Clinical Cardiac Electrophysiology $609
Cardiovascular Disease $238
Thoracic Surgery (Cardiothoracic Vascular Surgery) $32.45

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Safeguard Focus

These are the largest totals companies reported as associated with Safeguard Focus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Hallisey Hartford, CT Vascular & Interventional Radiology $346,042.76
Ryan Lewis South Jordan, UT General Practice $3,562.50
Frederick Han San Diego, CA Clinical Cardiac Electrophysiology $164.57
Anne-Sophie Lacharite-Roberge La Jolla, CA Cardiovascular Disease $164.56
Jonathan Hsu San Diego, CA Clinical Cardiac Electrophysiology $164.56
Matthew Sellers Greenville, SC Clinical Cardiac Electrophysiology $131.98
Jeffrey Senfield Greenville, SC Clinical Cardiac Electrophysiology $131.98
Omid Yousefian Santa Barbara, CA Cardiovascular Disease $73.72
Michael Maxwell Bozeman, MT Thoracic Surgery (Cardiothoracic Vascular Surgery) $21.17
Ajit Janardhan Titusville, FL Clinical Cardiac Electrophysiology $15.88

Prescribed Safeguard Focus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.